Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Revascor in Heart Failure
NCT00721045Phase 2Completed
- Sponsor
- Mesoblast Ltd
- Start
- Aug 2008
- Primary completion
- Jun 2011
- Modality
- Small Interfering RNA (siRNA), Modified DNA Oligonucleotides, Single-strand DNA
- Countries
- 1
01
Overview
A Phase 2 trial of fomivirsen in heart failure (HF), sponsored by Mesoblast Ltd. Started Aug 2008; status: completed.
02
Drugs
fomivirsen
03
Conditions
heart failure (HF)
Beyond the preview
Go deeper on NCT00721045.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00721045.